André J. Müller
Directeur/Membre du Conseil chez Anokion SA
Postes actifs de André J. Müller
Sociétés | Poste | Début | Fin |
---|---|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Directeur/Membre du Conseil | - | - |
Historique de carrière de André J. Müller
Anciens postes connus de André J. Müller
Sociétés | Poste | Début | Fin |
---|---|---|---|
ADDEX THERAPEUTICS LTD | Président | 01/01/2002 | 27/06/2014 |
ACTELION | Directeur/Membre du Conseil | 01/01/2009 | 01/01/2009 |
Fondateur | 30/12/1999 | 01/04/2009 | |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Directeur en chef des Investissements | - | - |
Fondateur | - | - | |
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Directeur/Membre du Conseil | 01/01/1999 | - |
BIOGEN INC. | Directeur Financier/CFO | - | - |
ABIONYX PHARMA | Président | - | - |
Formation de André J. Müller
INSEAD | Masters Business Admin |
University of Geneva | Undergraduate Degree |
Statistiques
Internationale
Suisse | 7 |
France | 3 |
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 4 |
Chairman | 2 |
Founder | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
ABIONYX PHARMA | Health Technology |
BIOGEN INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Finance |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- André J. Müller
- Expérience